MGI to Divest Complete Genomics to Swiss Rockets AG for $50 Million
MGI has announced its decision to sell its entire stake in Complete Genomics to Swiss Rockets AG for approximately $50 million. Bloomberg posted on X, highlighting this strategic move as part of MGI's broader business realignment. The transaction is expected to enhance MGI's focus on its core operations while allowing Swiss Rockets AG to expand its portfolio in the genomics sector. The deal underscores the ongoing consolidation in the biotechnology industry, as companies seek to optimize their assets and strengthen their market positions.
Source: CoinLive The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments